The Allstate Corporation
NYSE:ALLInsurance - Property & Casualty
-$2.30 today
- Market cap
- $65.97B
- Beta
- 0.19
- P/E (TTM)
- 4.7
- EPS (TTM)
- $46.82
- Dividend yield
- 1.90%
Volume 1.38M
Average 1.52M
ALL Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
The Allstate CorporationNYSE: ALL
Research & Development · Q2 FY2026 · quarter ended Jun 2026
Research & development remains negative
Q2 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How ALL compares with its peers on the latest reported figures
- ALL's LTM Jun 2026 research & development of $0 is the highest of the 11 companies compared; the peer median is $0.
- Research & development amounts to 0.0% of revenue for ALL, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding ALL) | $0 | — | — | 0.0% | |
Competitors are the stored peer set for ALL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 48.68B | 50.62B | 56.59B | 63.52B | 66.46B |
| Cost of Revenue | 36.65B | 44.94B | 49.42B | 49.02B | 44.37B |
| Gross Profit | 12.03B | 5.68B | 7.17B | 14.5B | 22.09B |
| Gross Margin | 24.7% | 11.2% | 12.7% | 22.8% | 33.2% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | (644M) | 116M | 9M | (37M) | (30M) |
| Operating Expenses | 5.57B | 7.51B | 7.52B | 8.74B | 8.93B |
| Depreciation & Amortization | 1.09B | 847M | 704M | 555M | 482M |
| EBITDA | 7.88B | (648M) | 735M | 6.72B | 14.04B |
| EBITDA Margin | 16.2% | -1.3% | 1.3% | 10.6% | 21.1% |
| Operating Income | 6.47B | (1.83B) | (348M) | 5.76B | 13.16B |
| Operating Margin | 13.3% | -3.6% | -0.6% | 9.1% | 19.8% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 330M | 335M | 379M | 400M | 399M |
| Other Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | 6.47B | (1.83B) | (348M) | 5.76B | 13.16B |
| Pre-Tax Margin | 13.3% | -3.6% | -0.6% | 9.1% | 19.8% |
| Income Tax Expense | 1.29B | (488M) | (135M) | 1.16B | 2.89B |
| Net Income | 1.61B | (1.29B) | (188M) | 4.67B | 10.28B |
| Net Margin | 3.3% | -2.5% | -0.3% | 7.3% | 15.5% |
| EPS (Basic) | 5.04 | (5.03) | (1.20) | 17.22 | 38.68 |
| EPS (Diluted) | 4.96 | (5.03) | (1.20) | 16.99 | 38.19 |
| Weighted Avg Shares | 294.8M | 271.2M | 262.5M | 264.3M | 261.3M |
| Weighted Avg Shares (Diluted) | 299.1M | 271.2M | 262.5M | 267.8M | 264.7M |
The Allstate Corporation
NYSE:ALL
Intrinsic Alpha fair value
Locked
Current Price
$266.59
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.